JSCRX | VISGX | JSCRX / VISGX | |
Total Expense Ratio | 1.31 | 0.19 | 689% |
Annual Report Gross Expense Ratio | 1.56 | 0.19 | 821% |
Fund Existence | 21 years | 27 years | - |
Gain YTD | -6.684 | -4.531 | 148% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.97B | 35B | 8% |
Annual Yield % from dividends | 0.41 | 0.44 | 92% |
Returns for 1 year | 1.14 | 7.11 | 16% |
Returns for 3 years | 15.94 | 38.50 | 41% |
Returns for 5 years | 8.18 | 40.29 | 20% |
Returns for 10 years | -30.51 | 100.60 | -30% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ADNPX | 16.67 | 0.03 | +0.18% |
American Beacon ARK Transfmt Innov Inv | |||
RYHAX | 103.38 | -0.84 | -0.81% |
Rydex Health Care H | |||
LMGAX | 26.22 | -0.29 | -1.09% |
Lord Abbett Growth Opportunities A | |||
AEYGX | 33.61 | -0.49 | -1.44% |
American Century Equity Growth R5 | |||
LMGFX | 71.20 | -1.18 | -1.63% |
ClearBridge International Growth FI |